Literature DB >> 17332448

Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study.

Carlo Bruno Giorda1, Angelo Avogaro, Marina Maggini, Flavia Lombardo, Edoardo Mannucci, Salvatore Turco, Stefania Spila Alegiani, Roberto Raschetti, Mario Velussi, Ele Ferrannini.   

Abstract

BACKGROUND AND
PURPOSE: Type 2 diabetes mellitus is a strong predictor of cerebrovascular disease, yet few studies have assessed the incidence of stroke and the role of other risk factors in unselected type 2 diabetes mellitus populations.
METHODS: We prospectively followed-up 14,432 type 2 diabetes mellitus patients, aged 40 to 97 years, with and without a history of cardiovascular disease at enrollment, and we estimated the incidence of stroke and the hazards ratios with respect to clinical variables.
RESULTS: During a 4-year follow-up, 296 incident stroke events were recorded. In persons with no history of cardiovascular disease, the age-standardized incidence of stroke (per 1000 person-years) was 5.5 (95% confidence interval, 4.2 to 6.8) in men and 6.3 (95% confidence interval, 4.5 to 8.2) in women. In persons with a history of cardiovascular disease, it was 13.7 (95% confidence interval, 7.5 to 19.8) in men and 10.8 (95% confidence interval, 7.3 to 14.4) in women. The hazards ratios of stroke incidence varied according to age, sex, and history of cardiovascular disease. Among men with no history, HbA1c and smoking were predictors of stroke. Among patients with a history, the risk factors were, in men, therapy with insulin plus oral agents, treated high total cholesterol and low HDL cholesterol, whereas in women microvascular complications were a risk factor. Previous stroke was a strong predictor of stroke in both sexes.
CONCLUSIONS: Age and previous stroke are the main predictors of stroke in diabetes. The combined role of Hba1c, microvascular complications, low HDL cholesterol, and treatment with insulin plus oral agents highlights the importance of diabetic history and clinical background in the development of stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332448     DOI: 10.1161/01.STR.0000260100.71665.2f

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  32 in total

1.  DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high-glucose conditions, potentially through the SIRT1/HIF-1/VEGF pathway.

Authors:  Dong-Hua Mi; Hong-Juan Fang; Guang-Hui Zheng; Xian-Hong Liang; Ya-Rong Ding; Xin Liu; Li-Ping Liu
Journal:  CNS Neurosci Ther       Date:  2018-08-23       Impact factor: 5.243

2.  Sex differences in cardiovascular risk profiles of ischemic stroke patients with diabetes in the Greater Cincinnati/Northern Kentucky Stroke Study.

Authors:  Tracy E Madsen; Jane C Khoury; Kathleen A Alwell; Charles J Moomaw; Stacie L Demel; Matthew L Flaherty; Daniel Woo; Jason Mackey; Felipe De Los Rios La Rosa; Sharyl Martini; Simona Ferioli; Opeolu Adeoye; Pooja Khatri; Brett M Kissela; Dawn Kleindorfer
Journal:  J Diabetes       Date:  2017-08-09       Impact factor: 4.006

3.  Impairment of the glymphatic system after diabetes.

Authors:  Quan Jiang; Li Zhang; Guangliang Ding; Esmaeil Davoodi-Bojd; Qingjiang Li; Lian Li; Neema Sadry; Maiken Nedergaard; Michael Chopp; Zhenggang Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population.

Authors:  Jane C Khoury; Dawn Kleindorfer; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Simona Ferioli; Joseph P Broderick; Brett M Kissela
Journal:  Stroke       Date:  2013-04-25       Impact factor: 7.914

Review 5.  Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence.

Authors:  Vivian A Fonseca; Yehuda Handelsman; Bart Staels
Journal:  Diabetes Obes Metab       Date:  2010-05       Impact factor: 6.577

Review 6.  Diabetes and sex: from pathophysiology to personalized medicine.

Authors:  Rosanna Abbate; Edoardo Mannucci; Gabriele Cioni; Cinzia Fatini; Rossella Marcucci
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

7.  A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus.

Authors:  Theresa Dombi; Kenneth K Kwok; Marla B Sultan
Journal:  BMC Ophthalmol       Date:  2012-08-08       Impact factor: 2.209

8.  Smoking and type 2 diabetes mellitus.

Authors:  Sang Ah Chang
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

9.  GLP-1 secretion by microglial cells and decreased CNS expression in obesity.

Authors:  Camilla Kappe; Linda M Tracy; Cesare Patrone; Kerstin Iverfeldt; Åke Sjöholm
Journal:  J Neuroinflammation       Date:  2012-12-23       Impact factor: 8.322

10.  Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India.

Authors:  K R Thankappan; G K Mini; Meena Daivadanam; G Vijayakumar; P S Sarma; Mark Nichter
Journal:  BMC Public Health       Date:  2013-01-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.